Daniil Gataulin
Stock Analyst at Chardan Capital
(0.86)
# 3,473
Out of 4,670 analysts
51
Total ratings
24.32%
Success rate
-15.18%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGNX REGENXBIO | Maintains: Buy | $52 | $9.59 | +442.23% | 8 | Nov 20, 2024 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $36 | $5.93 | +507.08% | 2 | Nov 18, 2024 | |
| OCGN Ocugen | Maintains: Buy | $6 | $0.91 | +561.23% | 7 | Nov 18, 2024 | |
| CGTX Cognition Therapeutics | Maintains: Buy | $11 | $0.43 | +2,471.90% | 3 | Nov 15, 2024 | |
| FBRX Forte Biosciences | Maintains: Buy | $3 → $64 | $16.00 | +300.00% | 2 | Nov 15, 2024 | |
| CRVO CervoMed | Maintains: Buy | $55 | $9.60 | +472.92% | 2 | Nov 14, 2024 | |
| EYPT EyePoint Pharmaceuticals | Maintains: Buy | $28 → $33 | $8.95 | +268.72% | 8 | Nov 8, 2024 | |
| CLSD Clearside Biomedical | Maintains: Buy | $6 | $1.08 | +455.56% | 2 | Oct 14, 2024 | |
| OTLK Outlook Therapeutics | Maintains: Buy | $53 | $5.03 | +953.68% | 6 | Aug 16, 2024 | |
| ADVM Adverum Biotechnologies | Maintains: Buy | $4 → $40 | $6.04 | +562.25% | 5 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $14.76 | +103.25% | 3 | Jun 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $2.19 | +9,945.66% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.19 | - | 2 | Jul 25, 2023 |
REGENXBIO
Nov 20, 2024
Maintains: Buy
Price Target: $52
Current: $9.59
Upside: +442.23%
MeiraGTx Holdings
Nov 18, 2024
Maintains: Buy
Price Target: $36
Current: $5.93
Upside: +507.08%
Ocugen
Nov 18, 2024
Maintains: Buy
Price Target: $6
Current: $0.91
Upside: +561.23%
Cognition Therapeutics
Nov 15, 2024
Maintains: Buy
Price Target: $11
Current: $0.43
Upside: +2,471.90%
Forte Biosciences
Nov 15, 2024
Maintains: Buy
Price Target: $3 → $64
Current: $16.00
Upside: +300.00%
CervoMed
Nov 14, 2024
Maintains: Buy
Price Target: $55
Current: $9.60
Upside: +472.92%
EyePoint Pharmaceuticals
Nov 8, 2024
Maintains: Buy
Price Target: $28 → $33
Current: $8.95
Upside: +268.72%
Clearside Biomedical
Oct 14, 2024
Maintains: Buy
Price Target: $6
Current: $1.08
Upside: +455.56%
Outlook Therapeutics
Aug 16, 2024
Maintains: Buy
Price Target: $53
Current: $5.03
Upside: +953.68%
Adverum Biotechnologies
Jul 18, 2024
Maintains: Buy
Price Target: $4 → $40
Current: $6.04
Upside: +562.25%
Jun 11, 2024
Reiterates: Buy
Price Target: $30
Current: $14.76
Upside: +103.25%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $2.19
Upside: +9,945.66%
Jul 25, 2023
Downgrades: Neutral
Price Target: n/a
Current: $6.19
Upside: -